Redirect Notice

Looks like you clickedhttps://multiplesclerosis.net/news/ocrevus-ocrelizumab-the-first-disease-modifying-therapy-for-primary-progressive-ms-approved-by-the-fda/

If you do not want to visit that page, you can close this browser tab.